Literature DB >> 22939581

Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial).

Kenneth Tandjung1, K Gert van Houwelingen, Hanneke Jansen, Mounir W Z Basalus, Hanim Sen, Marije M Löwik, Martin G Stoel, J Hans W Louwerenburg, Frits H A F de Man, Gerard C M Linssen, Rogier Nijhuis, Mark B Nienhuis, Job van der Palen, Ronald P Stolk, Clemens von Birgelen.   

Abstract

In patients without a history of diabetes mellitus, increased levels of glycated hemoglobin (HbA1c) are associated with higher cardiovascular risk. The relation between undetected diabetes and clinical outcome after percutaneous coronary intervention is unknown. To investigate whether these patients may have an increased risk of periprocedural myocardial infarction (PMI), the most frequent adverse event after percutaneous coronary intervention, we assessed patients of the TWENTE trial (a randomized, controlled, second-generation drug-eluting stent trial) in whom HbA1c data were available. Patients were classified as known diabetics or patients without a history of diabetes who were subdivided into undetected diabetics (HbA1c ≥6.5%) and nondiabetics (HbA1c <6.5%). Systematic measurement of cardiac biomarkers and electrocardiographic assessment were performed. One-year clinical outcome was also compared. Of 626 patients, 44 (7%) were undetected diabetics, 181 (29%) were known diabetics, and 401 (64%) were nondiabetics. In undetected diabetics the PMI rate was higher than in nondiabetics (13.6% vs 3.7%, p = 0.01) and known diabetics (13.6% vs 6.1%, p = 0.11). Multivariate analysis adjusting for covariates confirmed a significantly higher PMI risk in undetected diabetics compared to nondiabetics (odds ratio 6.13, 95% confidence interval 2.07 to 18.13, p = 0.001) and known diabetics (odds ratio 3.73, 95% confidence interval 1.17 to 11.89, p = 0.03). After 1 year, target vessel MI rate was significantly higher in undetected diabetics (p = 0.02) than in nondiabetics, which was related mainly to differences in PMI. Target vessel failure was numerically larger in unknown diabetics than in nondiabetics, but this difference did not reach statistical significance (13.6% vs 8.0%, p = 0.25). In conclusion, undetected diabetics were shown to have an increased risk of PMI.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22939581     DOI: 10.1016/j.amjcard.2012.07.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.

Authors:  Jia Zheng; Jing Cheng; Qian Zhang; Cuijuan Qi; Tong Wang; Xinhua Xiao
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 2.  Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective study.

Authors:  Yong-Jin Jiang; Wei-Xing Han; Chao Gao; Jun Feng; Zheng-Fei Chen; Jing Zhang; Chun-Miao Luo; Jian-Yuan Pan
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Myeloid cell TNFR1 signaling dependent liver injury and inflammation upon BCG infection.

Authors:  Leslie Chavez-Galan; Dominique Vesin; Guillaume Blaser; Husnu Uysal; Sulayman Benmerzoug; Stéphanie Rose; Bernhard Ryffel; Valérie F J Quesniaux; Irene Garcia
Journal:  Sci Rep       Date:  2019-03-28       Impact factor: 4.379

4.  Comparison of the incidence of periprocedural myocardial infarction between percutaneous coronary intervention with versus without rotational atherectomy using propensity score-matching.

Authors:  Yusuke Mizuno; Kenichi Sakakura; Hiroyuki Jinnouchi; Yousuke Taniguchi; Takunori Tsukui; Kei Yamamoto; Masaru Seguchi; Hiroshi Wada; Hideo Fujita
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

5.  Analysis of risk factors of ST-segment elevation myocardial infarction in young patients.

Authors:  Wang Yunyun; Li Tong; Liu Yingwu; Liu Bojiang; Wang Yu; Hu Xiaomin; Li Xin; Peng Wenjin; JinFang Li
Journal:  BMC Cardiovasc Disord       Date:  2014-12-09       Impact factor: 2.298

6.  Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study.

Authors:  Shengjia Sun; Yang Ou; Haiming Shi; Jianfeng Luo; Xinping Luo; Yunzhi Shen; Yufei Chen; Xiaojin Liu; Zhidong Zhu; Wei Shen
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

7.  Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.

Authors:  Eline H Ploumen; Rosaly A Buiten; Marlies M Kok; Carine J M Doggen; K Gert van Houwelingen; Martin G Stoel; Frits H A F de Man; Marc Hartmann; Paolo Zocca; Gerard C M Linssen; Cees Doelman; Gert D Kant; Clemens von Birgelen
Journal:  Catheter Cardiovasc Interv       Date:  2019-10-17       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.